These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4054224)

  • 1. Steroid diagnosis of Cushing's syndrome evaluated by pattern recognition.
    Kreze A; Mikulecký M; Simko I
    Exp Clin Endocrinol; 1985 Aug; 86(1):74-8. PubMed ID: 4054224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's syndrome. Screening methods in hospitalized patients.
    Dunlap NE; Grizzle WE; Siegel AL
    Arch Pathol Lab Med; 1985 Mar; 109(3):222-9. PubMed ID: 3838451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-conjugated versus total urinary cortisol in the diagnosis of Cushing's syndrome.
    Kohek MB; Nicolau W; Mendonca BB
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(5):222-4. PubMed ID: 10436629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24-hour serum concentration profile of cortisol in patients with Cushing's disease.
    Pirich K; Vierhapper H
    Exp Clin Endocrinol; 1988 Mar; 92(3):275-9. PubMed ID: 2855318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of plasma cortisol patterns in normal subjects and in Cushing's syndrome.
    Vagnucci AH; Wang TP; Pratt V; Li CC
    IEEE Trans Biomed Eng; 1991 Feb; 38(2):113-25. PubMed ID: 2066120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
    Görges R; Knappe G; Gerl H; Ventz M; Stahl F
    J Endocrinol Invest; 1999 Apr; 22(4):241-9. PubMed ID: 10342356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of endocrine tests. B: screening for hypercortisolism.
    Holleman F; Endert E; Prummel MF; van Vessem-Timmermans M; Wiersinga WM; Fliers E
    Neth J Med; 2005 Oct; 63(9):348-53. PubMed ID: 16244382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Free urinary cortisol in the diagnosis of hypercorticism].
    Subeska-Stratrova S; Nesović M; Manojlović D; Marinković J; Pancevska S
    Med Pregl; 1993; 46(5-6):173-6. PubMed ID: 7869969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A follow-up of the "low dose suppressible" hypercortisolism.
    Kreze A; Velemínský J; Spirová E
    Endocrinol Exp; 1983 Jun; 17(2):119-23. PubMed ID: 6603966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of CRF-41 in the differential diagnosis of Cushing's syndrome and obesity.
    Grossman A; Howlett TA; Kopelman PG
    Horm Metab Res Suppl; 1987; 16():62-4. PubMed ID: 2832293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Free urinary cortisol in the diagnosis of Cushing's syndrome].
    Kreze A; Velemínský J; Putz Z
    Cas Lek Cesk; 1984 Dec; 123(50):1536-40. PubMed ID: 6509503
    [No Abstract]   [Full Text] [Related]  

  • 15. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
    Friedman TC
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of hypothalamic-pituitary-adrenocortical function tests in patients with Cushing's syndrome.
    Hashimoto K
    Acta Med Okayama; 1975 Apr; 29(2):111-26. PubMed ID: 169671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients].
    Contreras LN; Cardoso E; Lozano MP; Pozzo J; Pagano P; Claus-Hermbeg H
    Medicina (B Aires); 2000; 60(3):326-30. PubMed ID: 11050809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantification of the differential diagnosis of Cushing's syndrome using computers].
    Kreze A; Mikulecký M; Hulkó G
    Exp Clin Endocrinol; 1983 Nov; 82(3):363-7. PubMed ID: 6360700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW; Beardwell CG
    Q J Med; 1973 Jan; 42(165):175-204. PubMed ID: 4688791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.